Weight Management

Semaglutide (Rybelsus) is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.

Surgical procedures and weight-loss drugs combat high hypertension in individuals who are obese or overweight, according to the American Heart Association.

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.

Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease, and 17% less likely to develop heart failure.

In addition to early screening, counseling patients on preventive interventions can reduce the risk of developing prediabetes or type 2 diabetes.

Additionally, among this population, combining aerobic exercise with a moderate reduction in daily calories resulted in greater improvements in aortic stiffness versus exercise only or exercise plus a more restrictive diet.

Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.

Clive Ward Able, MD, BPharm, discusses research results suggesting the promise of psilocybin as a potential treatment for obesity.

Patients at risk for diabetes should try to focus on adhering to their medications, diet and exercise to reduce their blood sugars, which will decrease their A1C levels.

According to a press release from Saniona, Tesomet is the first and only investigational treatment for HO to receive orphan drug designation.

Pharmacy Times interviewed Dennis O’Neill, president and board member of BIOMEDICAN, on the outlook around the future of biosynthesis therapeutics that use rare cannabinoids to treat a range of health issues, from mental health disorders to diabetes.

The shift to telemedicine for patient care for individuals with diabetes showed little negative impact on the metabolic health of these patients.

Clive Ward Able, MD, BPharm, president of Clintell, consultant to NeonMind Inc, and a trained pharmacist and physician, discusses his research into the use of psychedelic compounds to treat obesity.

Individuals with at least one inactive copy of the gene have lower BMIs and, on average, face a 54% lower risk of obesity than individuals without the mutations.

No significant differences were found in blood pressure, blood sugar levels, or kidney function when comparing both medications among patients with type 2 diabetes.

The research concluded that eating starchy snacks after meals and eating a Western-style lunch containing refined grains, cheese, and cured meat elevates the risk of dying from heart disease and other illnesses.

The results from the first phase 3 SURPASS trials showed promising results with tirzepatide in patients with type 2 diabetes.

This study was among the first to display the adverse relationship in younger adults, according to the letter.

Study presented at the American Diabetes Association (ADA) 81st Scientific Sessions shows meaningful outcomes for people with diabetes who use the FreeStyle Libre system.

Improvements in glycemic control were seen as early as 3 months after program implementation and were sustained up to a year with continued program engagement.

Researchers observed improvements in total cholesterol, low-density lipoprotein, triglycerides, and serum gamma glutamyl transferase among patients both with and without diabetes.

Myokine cathepsin B, brain-derived neurotrophic factor, and klotho were all found to be influential in delaying the progression of Alzheimer disease.

The investigators conducted a systematic review of the existing literature using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to evaluate the efficacy of dietary supplements and alternative therapies for weight loss in participants aged 18 and older.

Further, the ISCs reside in a series of regularly folded valleys of the gut, which the researchers call crypts.

Researchers noted decreases in control of blood pressure as well as non¬–high-density lipoprotein cholesterol, both of which are risk factors for diabetes.

Pharmacists play an important role in assisting with hypertension treatment by helping to modify blood pressure therapies when patients experience adverse effects or helping if a patient has difficulty remembering to take their medications.

Continuous glucose monitors were associated with a decline in levels of HbA1c as well as reduced emergency department visits and hospitalizations for hypoglycemia.

By encouraging patients to find activities they enjoy and celebrating small improvements, health care professionals can help patients improve mild to moderate hypertension and elevated cholesterol.

Semaglutide (Wegovy) injection is indicated for use with a reduced calorie meal plan and increased physical activity to help adults with obesity or overweight, who also have weight-related medical problems, lose weight and maintain weight loss.